Implantable gastric stimulation alters expression of oxytocin- and orexin-containing neurons in the hypothalamus of rats

Obesity Surgery

Volumn 16, Issue 6, 2006, Pages 762-769

  Tang, Ming ^a   Zhang, Jing ^a,b   Xu, Luo ^a   Chen, Jiande ^b,c  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NONE   (United States)

Author keywords

cFos; Gastric electrical stimulation; Immunocytochemistry; Morbid obesity; Obesity; Orexin; Oxytocin

Indexed keywords

ANTISERUM; NEUROPEPTIDE; OREXIN; OXYTOCIN; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMPLANTABLE GASTRIC STIMULATION; MALE; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROVOCATION TEST; RAT; SUPRAOPTIC NUCLEUS;

ANIMALS; APPETITE; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEURONS; NEUROPEPTIDES; OXYTOCIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SATIETY RESPONSE;

EID: 33744988792     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206777346745     Document Type: Article

References (46)

1. Kuczmarski RJ, Flegal KM, Campbell SM et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205-11.
2. Klein S. Obesity. Clin Perspect Gastroenterol 2000; 3: 232-6.
3. Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 2004; 14 (Suppl 1): S14-S22.
4. Miller KA. Implantable electrical gastric stimulation to treat morbid obesity in the human: operative technique. Obes Surg 2002; 12 (Suppl 1): 17S-20S.
5. Shikora SA. Implantable gastric stimulation for the treatment of severe obesity. Obes Surg 2004; 14: 545-8.
6. Ouyang H, Yin J, Chen JD. Therapeutic potential of gastric electrical stimulation for obesity and its possible mechanisms: a preliminary canine study. Dig Dis Sci 2003; 48: 698-705.
7. De Luca M, Segato G, Busetto L et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg 2004; 14 (Suppl 1): S33-S39.
8. Paxions G, Watson C. Rat brain in stereotaxic coordinate. London: Academic Press 1982.
9. Chen JDZ. Mechanisms of an implantable gastric stimulator for obesity. Obes Surg 2004; 14 (Suppl 1): S28-S32.
10. Lei Y, Xing J, Chen JDZ. Effects and mechanisms of implantable gastric stimulation on proximal gastric distention in conscious dogs. Obes Surg 2005; 15: 528-33.
11. Zhu HB, Chen JDZ. Implantable gastric stimulation inhibits gastric motility via sympathetic pathway in dogs. Obes Surg 2005; 15: 95-100.
12. Qin C, Sun Y, Foreman R. Gastric electrical stimulation modulates neuronal activity in nucleus tractus solitarii in rats. Auton Neurosci 2005; 119: 1-8.
13. Tang M, Zhang J, Chen JD. Central mechanisms of gastric electrical stimulation involving neurons in the paraventricular nucleus of hypothalamus in rats. Obes Surg 2006; 16: 344-52.
14. Hetherington AW, Ranson SW. Hypothalamic lesions and adiposity in the rat. Anat Rec 1940; 78: 149-72.
15. Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951; 24: 123-40.
16. Kalar SP, Dube MG, Pu MG et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68-100.
17. Tang M, Ni H, Xu L et al. Changes in the mRNA concentration of preprocholecystokinin in rat cerebral cortex and hippocampus after gastric distension. Shenli Xuebao 1999; 51: 488-94.
18. Fujimiya M, Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides 2000; 21: 1565-82.
19. Tang M, Zhang HY, Jiang ZY. Effect of central administration of motilin on the activity of gastric-related neurons in brain stem and gastric motility of rats. Shengli Xuebao 2000; 52: 416-20.
20. Guan YF, Tang M, Jiang ZY et al. Excitatory effects of motilin in the hippocampus on gastric motility in rats. Brain Res 2003; 984: 33-41.
21. Moran TH, Kinzig KP. Gastrointestinal satiety signal II. Cholecyastokin. Am J Physiol Gastrointest Liver Physiol 2004; 86: G183-188.
22. Konturek SJ, Konturek JW, Pawlik T et al. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 2004; 55: 137-54.
23. Park ES, Yi SJ, Kim JS et al. Changes in orexin-A and neuropeptide Y expression in the hypothalamus of the fasted and high-fat diet fed rats. J Vet Sci 2004; 5: 295-302.
24. Korbonits M, Goldstone AP, Gueorguiev M et al. Ghrelin - a hormone with multiple functions. Frontiers in Neuroendocrinology 2004; 25: 27-68.
25. Asakawa A, Inui A, Kaga T et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-45.
26. Morely JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987; 8: 256-87.
27. Morely JE, Levine AS. The central control of appetite. Lancet 1981; 1: 389-401.
28. Sakurai T, Amemiya A, Ishii M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
29. Tach Y, Garrick T, Raybould H. Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology 1990; 98: 517-28.
30. Schwartz MW, Woods SC, Porte D Jr et al. Central nervous system control of food intake. Nature 2000; 404: 661-71.
31. Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 2003; 11: 1456-62.
32. Verty AN, McFarlane JR, McGregor IS et al. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology 2004; 47: 593-603.
33. Blevins JE, Schwartz MW, Baskin DG. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Integrat Compar Physiol 2004; 287: R87-96.
34. Zheng H, Corkern M, Stoyanova I et al. Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. Am J Physiol Integrat Compar Physiol 2003; 284: R1436-44.
35. Rinaman L, Rothe EE. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiol Integrat Compar Physiol 2002; 283: R99-106.
36. Diaz-Cabiale Z, Narvaez JA, Petersson M et al. Oxytocin/alpha(2)- Adrenoceptor interactions in feeding responses. Neuroendocrinology 2000; 71: 209-18.
37. Nelson EE, Alberts JR, Tian Y et al. Oxytocin is elevated in plasma of 10-day-old rats following gastric distension. Brain Res 1998; 111: 301-3.
38. Mieda M, Williams SC, Sinton CM et al. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004; 24: 10493-501.
39. Zheng H, Patterson LM, Berthoud HR. Orexin-A projections to the caudal medulla and orexin-induced c-Fos expression, food intake, and autonomic function. J Compara Neurol 2005; 485: 127-42.
40. Levine AS, Winsky-Sommerer R, Huitron-Resendiz S et al. Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. Am J Physiol Integra Compar Physiol 2005; 288: R1727-32.
41. Schwartz GJ. Biology of eating behavior in obesity. Obes Res 2004; 12 (Suppl): 102S-106S.
42. Akiyama M, Yuasa T, Hayasaka N et al. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur J Neurosci 2004; 20: 3054-62.
43. Johren O, Bruggemann N, Dominiak P. Orexins (hypocretins) and adrenal function. Hormone Metab Res 2004; 36: 370-5.
44. Schwartz GJ, Azzara AV. Sensory neurobiological analysis of neuropeptide modulation of meal size. Physiol Behav 2004; 82: 81-7.
45. Kiwaki K, Kotz CM, Wang C et al. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocr Metab 2004; 286: E551-9.
46. Cai XJ, Evans ML, Lister CA et al. Hypoglycemis activates orexin neurons and selectively increases hypothalamic orexin-B levels. Responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001; 50: 105-12.